Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 7INDUSTRY 2NIH 1

Study Type

Interventional 3Observational 1

Sponsor

Cancer Type

Head & Neck 1Endocrine 1

Conditions

Neoplasms 172Breast Neoplasms 102Prostatic Neoplasms 45Lung Neoplasms 42Lymphoma 37Leukemia 35Brain Neoplasms 35Melanoma 29Ovarian Neoplasms 24Lymphoma, Non-Hodgkin 20Stomach Neoplasms 18HIV Infections 17Colonic Neoplasms 17Esophageal Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Urinary Bladder Neoplasms 15Glioma 15Acquired Immunodeficiency Syndrome 15Sarcoma, Kaposi 14Neoplasm Metastasis 14Leukemia, Myeloid, Acute 14Thyroid Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 13Kidney Neoplasms 13Hematologic Neoplasms 13Endometrial Neoplasms 13Colorectal Neoplasms 13Uterine Cervical Neoplasms 12Sarcoma 12Neurofibromatosis 1 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Observational × Hypothyroidism × Clear all
NCT01441154 2020-09-28

Metabolic Effects of Synthetic Thyroid Hormone for Thyroid Cancer Treatment

National Institutes of Health Clinical Center (CC)

Completed
16 enrolled
EndocrineHead & Neck

Thyroid cancer, Hurthle cell, Thyroid Cancer, Papillary, Hypothyroidism, Thyroid Neoplasms, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡